Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-11-09FDA Approved: PRADAXA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals Inc.)
FDA approved Boehringer Ingelheim Pharmaceuticals' supplemental application for Pradaxa (dabigatran etexilate mesylate).
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Prevalence of Pulmonary Embolism in ICU
Completed clinical trial update reporting on the prevalence of pulmonary embolism in ICU patients, including co-occurrence with deep vein th…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation [Phase 4]
Phase 4 clinical trial evaluating Echo Doppler score and D-dimer level for assessing recurrence of venous thromboembolism after stopping ant…
-
CLINICAL_TRIALS trial_result · 2011-09-26Clinical Trial Update: Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery [NA]
Clinical trial update evaluating prophylaxis to prevent deep vein thrombosis and pulmonary embolism after primary hip or knee replacement; t…
-
CLINICAL_TRIALS research · 2011-08-23Clinical Trial Update: Aspirin for the Prevention of Recurrent Venous Thromboembolism [Phase 2, Phase 3]
This clinical trial update covers aspirin being studied in Phase 2 and Phase 3 trials to prevent recurrent venous thromboembolism. The trial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Simple Warfarin Dosing Algorithm Study [NA]
Completed clinical trial evaluating a simple dosing algorithm for warfarin to optimize anticoagulation dosing.
-
FDA approval · 2011-07-11FDA Approved: FONDAPARINUX SODIUM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved the generic fondaparinux sodium product from Dr. Reddy's Laboratories Limited under ANDA 091316. This approval provides a gener…
-
FDA approval · 2011-07-01FDA Approved: XARELTO — Original Application (Janssen Pharmaceuticals, Inc.)
The FDA documents the approval of the original application for Xarelto (rivaroxaban) from Janssen Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Prognostic Value of Computed Tomography (CT) Scan in Hemodynamically Stable Patients With Acute Symptomatic Pulmonary Embolism
This completed trial investigates whether CT scan features can prognosticate outcomes in hemodynamically stable patients with acute symptoma…
-
CLINICAL_TRIALS research · 2011-06-03Clinical Trial Update: Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
A clinical trial update examining whether antepartum thromboprophylaxis is needed for pregnant women with one prior venous thromboembolism; …
-
CLINICAL_TRIALS trial_result · 2011-06-01Clinical Trial Update: Discharge ALERT: Quality Improvement Initiative [NA]
This completed study reports on a discharge-alert quality improvement initiative aimed at improving venous thromboembolism prophylaxis and p…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)
This clinical trial update reports on the risk of stroke in patients with pulmonary embolism who have a patent foramen ovale (PFO); the stud…
-
CLINICAL_TRIALS research · 2011-05-13Clinical Trial Update: Surfactant Associated Protein - A Novel Marker for the Diagnosis of Pulmonary Embolism
The document discusses a clinical trial evaluating surfactant-associated protein as a novel biomarker for diagnosing pulmonary embolism. The…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. [NA]
A prospective, multi-center, single-arm study evaluated the safety of retrieving the Recovery G2 inferior vena cava filter; results were pos…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Safer Warfarin Treatment
A clinical trial evaluating safer warfarin treatment for conditions including atrial fibrillation and venous thromboembolism has been suspen…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Total Endoprosthesis
This clinical trial evaluates whether high-sensitivity troponin T and copeptin can serve as prognostic biomarkers in patients undergoing ele…
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis [Phase 3]
A Phase 3 trial of SR34006 in patients who completed 6 months of treatment for symptomatic pulmonary embolism or deep vein thrombosis has co…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism [Phase 3]
A Phase 3 study comparing dabigatran etexilate with warfarin for six months of treatment in adults with acute symptomatic venous thromboembo…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery [Phase 3]
Phase 3 trial comparing dabigatran etexilate 150 mg or 220 mg once daily with enoxaparin for prevention of venous thromboembolism after knee…
-
CLINICAL_TRIALS withdrawal · 2010-12-10Clinical Trial Update: Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis [Phase 3]
A Phase 3 trial investigating rosuvastatin for prevention of thrombosis in patients with prior venous thrombosis and pulmonary embolism has …
-
CLINICAL_TRIALS other · 2010-12-06Clinical Trial Update: Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis [Phase 4]
Clinical trial update about a Phase 4 study evaluating two weeks of low molecular weight heparin for distal vein thrombosis; the current sta…
-
FDA approval · 2010-10-19FDA Approved: PRADAXA — Original Application (Boehringer Ingelheim Pharmaceuticals Inc.)
The FDA approved Pradaxa (dabigatran etexilate mesylate) under an original NDA from Boehringer Ingelheim Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation
This is a completed clinical trial update describing a multi-detector CT chest imaging protocol and presenting case studies involving vascul…
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: V/Q SPECT for Diagnosis of Pulmonary Embolism
A completed clinical trial evaluating V/Q SPECT as a diagnostic method for pulmonary embolism.
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
A completed trial evaluating Fragmin (dalteparin) for treatment of acute deep vein thrombosis in cancer patients, with or without pulmonary …